News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
90,454 Results
Type
Article (3013)
Company Profile (20)
Press Release (87421)
Section
Business (38708)
Career Advice (58)
Deals (5958)
Drug Delivery (11)
Drug Development (11554)
Employer Resources (7)
FDA (2089)
Job Trends (2382)
News (56085)
Policy (3420)
Tag
Academia (275)
Accelerated approval (2)
Adcomms (2)
Allergies (20)
Alliances (3547)
ALS (6)
Alzheimer's disease (178)
Antibody-drug conjugate (ADC) (25)
Approvals (2127)
Artificial intelligence (20)
Autoimmune disease (2)
Bankruptcy (17)
Best Places to Work (2201)
Biosimilars (16)
Biotechnology (14)
Bladder cancer (25)
Brain cancer (1)
Breast cancer (69)
Cancer (453)
Cardiovascular disease (25)
Career advice (52)
Career pathing (2)
CAR-T (11)
Cell therapy (40)
Cervical cancer (3)
Clinical research (10283)
Collaboration (79)
Compensation (82)
Complete response letters (2)
COVID-19 (222)
CRISPR (7)
C-suite (18)
Cystic fibrosis (16)
Data (483)
Depression (10)
Diabetes (37)
Diagnostics (866)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (16)
Drug pricing (8)
Drug shortages (3)
Duchenne muscular dystrophy (19)
Earnings (32793)
Editorial (7)
Employer branding (2)
Employer resources (6)
Events (11088)
Executive appointments (36)
FDA (2366)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (66)
Gene editing (16)
Generative AI (2)
Gene therapy (37)
GLP-1 (106)
Government (443)
Grass and pollen (1)
Guidances (102)
Healthcare (2842)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (17)
Indications (11)
Infectious disease (246)
Inflammatory bowel disease (20)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (6)
Interviews (6)
IPO (4252)
IRA (3)
Job creations (294)
Job search strategy (46)
Kidney cancer (3)
Labor market (11)
Layoffs (59)
Leadership (1)
Legal (572)
Liver cancer (9)
Lung cancer (80)
Lymphoma (52)
Management (2)
Manufacturing (23)
MASH (13)
Medical device (2127)
Medtech (2127)
Mergers & acquisitions (1784)
Metabolic disorders (85)
Multiple sclerosis (17)
NASH (3)
Neurodegenerative disease (8)
Neuropsychiatric disorders (4)
Neuroscience (248)
NextGen: Class of 2025 (795)
Non-profit (388)
Now hiring (4)
Obesity (39)
Opinion (6)
Ovarian cancer (20)
Pain (11)
Pancreatic cancer (13)
Parkinson's disease (23)
Partnered (1)
Patents (20)
Patient recruitment (10)
Peanut (10)
People (3029)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase I (2447)
Phase II (4197)
Phase III (4338)
Pipeline (668)
Policy (3)
Postmarket research (441)
Preclinical (692)
Press Release (1)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (49)
Rare diseases (53)
Real estate (381)
Recruiting (2)
Regulatory (2699)
Reports (11)
Research institute (202)
Resumes & cover letters (2)
Rett syndrome (1)
RSV (12)
Schizophrenia (7)
Series A (8)
Series B (10)
Service/supplier (2)
Sickle cell disease (6)
Special edition (5)
Spinal muscular atrophy (48)
Sponsored (2)
Startups (255)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (2)
Vaccines (64)
Venture capitalists (6)
Weight loss (20)
Women's health (2)
Worklife (3)
Date
Last 7 days (293)
Last 30 days (598)
Last 365 days (5741)
2025 (2178)
2024 (6123)
2023 (6916)
2022 (8318)
2021 (8139)
2020 (8155)
2019 (6924)
2018 (5075)
2017 (4621)
2016 (3831)
2015 (4361)
2014 (3190)
2013 (2086)
2012 (2497)
2011 (2731)
2010 (2789)
Location
Africa (67)
Alabama (23)
Alaska (1)
Arizona (21)
Asia (5200)
Australia (895)
California (1055)
Canada (328)
China (59)
Colorado (42)
Connecticut (42)
Delaware (49)
Europe (14203)
Florida (173)
Georgia (35)
Idaho (8)
Illinois (71)
India (3)
Indiana (77)
Iowa (3)
Japan (47)
Kansas (10)
Kentucky (6)
Louisiana (4)
Maine (18)
Maryland (128)
Massachusetts (853)
Michigan (26)
Minnesota (72)
Missouri (7)
Montana (3)
Nebraska (2)
Nevada (10)
New Hampshire (13)
New Jersey (324)
New York (291)
North Carolina (143)
North Dakota (1)
Northern California (519)
Ohio (28)
Oklahoma (1)
Oregon (1)
Pennsylvania (240)
South America (107)
South Carolina (2)
Southern California (413)
Tennessee (6)
Texas (141)
United States (3988)
Utah (29)
Virginia (8)
Washington D.C. (3)
Washington State (120)
Wisconsin (5)
90,454 Results for "32".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Caribou Changes Course Again, Lays Off 32% of Workforce
The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The move follows a reconfiguration last year to move into immunology.
April 25, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity
May 6, 2025
·
2 min read
Press Releases
Nuclear Medicine Market Size to Hit USD 32.40 Billion by 203
February 19, 2025
·
1 min read
Press Releases
Metabolomics Market Size Expand $11.32 Bn at 13.43% CAGR by 2034
February 27, 2025
·
1 min read
Press Releases
Q32 Bio Joins Russell 3000® Index
Q32 Bio Inc. today announced that the company is joining the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell Indexes annual reconstitution, effective upon the U.S. market opening today, July 1, 2024.
July 1, 2024
·
6 min read
Press Releases
Cell Culture Media Market Size Expects USD 20.32 Bn Growing at 11.45% CAGR by 2034
February 27, 2025
·
1 min read
Business
Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio
Eli Lilly on Monday announced a $3.2 billion all-cash deal to purchase Morphic and its pipeline of oral integrin therapies in a move to expand the pharma’s presence in the autoimmune diseases space.
July 8, 2024
·
2 min read
·
Tristan Manalac
Deals
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split - June 6, 2024
Tonix Pharmaceuticals Holding Corp. today announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock.
June 6, 2024
·
4 min read
Press Releases
Deciphex Secures $32.3M Series C to Address Global Pathology Shortage
January 7, 2025
·
3 min read
Press Releases
Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million
January 31, 2025
·
5 min read
1 of 9,046
Next
